BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Diagnosis
283 results:

  • 1. Challenges in diagnosis and Treatment of Male Hypogonadism.
    Purnamasari D
    Acta Med Indones; 2024 Jan; 56(1):1-2. PubMed ID: 38561883
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels.
    Syriha A; Pantzios S; Mandilara D; Galanis P; Stathopoulou I; Barla G; Elefsiniotis I
    Cancer Med; 2024 Feb; 13(3):e6825. PubMed ID: 38361401
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Minimally invasive liver resection for cholangiolocellular carcinoma: A single-institution experience.
    Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
    Asian J Endosc Surg; 2024 Jan; 17(1):e13272. PubMed ID: 38212270
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker.
    Wu Q; Wang P; Peng Q; Kang Z; Deng Y; Li J; Chen Y; Li J; Ge F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069309
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
    Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
    Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Laparoscopic Management of Blunt Pancreatic Trauma in Adults and Pediatric Patients: A Systematic Review.
    Catellani B; Caracciolo D; Magistri P; Guidetti C; Menduni N; Yu H; Odorizzi R; Guerrini GP; Ballarin R; Di Sandro S; Di Benedetto F
    Biomed Res Int; 2023; 2023():9296570. PubMed ID: 37810623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Preoperative MRI features to predict vessels that encapsulate tumor clusters and microvascular invasion in hepatocellular carcinoma.
    Zhu Y; Yang L; Wang M; Pan J; Zhao Y; Huang H; Sun K; Chen F
    Eur J Radiol; 2023 Oct; 167():111089. PubMed ID: 37713969
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
    Fan Z; Jin M; Zhang L; Wang N; Li M; Wang C; Wei F; Zhang P; Du X; Sun X; Qiu W; Wang M; Wang H; Shi X; Ye J; Jiang C; Zhou J; Chai W; Qi J; Li T; Zhang R; Liu X; Huang B; Chai K; Cao Y; Mu W; Huang Y; Yang T; Zhang H; Qu L; Liu Y; Wang G; Lv G
    Gut; 2023 Nov; 72(11):2149-2163. PubMed ID: 37549980
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Woldesenbet S; Rueda BO; Yang J; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Shen F; Endo I; Pawlik TM
    Ann Surg; 2024 Mar; 279(3):471-478. PubMed ID: 37522251
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunotherapy for Advanced Hepatocellular Carcinoma-a Large Tertiary Center Experience.
    Raj R; Aykun N; Wehrle CJ; Maspero M; Krishnamurthi S; Estfan B; Kamath S; Aucejo F
    J Gastrointest Surg; 2023 Oct; 27(10):2126-2134. PubMed ID: 37464142
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
    Alshareefy Y; Shen CY; Prekash RJ
    Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The current and future burden of hepatitis B in Switzerland: a modelling study.
    Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
    Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients.
    Gong W; Wu J; Wei H; Jiang Z; Wan M; Wu C; Xue W; Ma R; Zhou X; Zhou H
    Radiol Med; 2023 Apr; 128(4):393-401. PubMed ID: 36943653
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-Transcriptome Sequencing Combined with High-Dimensional Proteomic Technologies Reveals the Potential Value of miR-135b-5p as a Biomarker for Hepatocellular Carcinoma.
    Zhang Y; He L; Pan L; Feng C; Wang X; Tao Y; Li T; Wang Q; Ullah H
    Biomed Res Int; 2023; 2023():6517963. PubMed ID: 36755690
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Innovative model of surface-enhanced Raman spectroscopy for exosomes identification: An approach for the diagnosis of hepatocellular carcinoma.
    Elkady A; Hassan M; Hagag MF; El-Ahwany E; Helal OM; Zoheiry M; Abdalla MA; Elzallat M
    Clin Chim Acta; 2023 Feb; 540():117228. PubMed ID: 36646368
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Challenges in the diagnosis of Epstein-Barr Virus-positive Inflammatory Follicular Dendritic Cell Sarcoma: Extremely Wide Morphologic Spectrum and Immunophenotype.
    Li Y; Yang X; Tao L; Zeng W; Zuo M; Li S; Wu L; Lin Y; Zhang Z; Yun J; Huang Y
    Am J Surg Pathol; 2023 Apr; 47(4):476-489. PubMed ID: 36574358
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serum CHI3L1 as a Biomarker for Non-invasive diagnosis of liver Fibrosis.
    Bao J; Ouyang Y; Qiao L; He J; Liu F; Wang Y; Miao L; Fu A; Lou Z; Zang Q; Huang W; Huang J; Li Z
    Discov Med; 2022; 33(168):41-49. PubMed ID: 36274212
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
    Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
    BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ethanolic extract of Coleus aromaticus leaves impedes the proliferation and instigates apoptotic cell death in liver cancer HepG2 cells through repressing JAK/STAT cascade.
    Shekh R; Tiwari RK; Ahmad A; Ahmad I; Alabdallah NM; Saeed M; Ansari IA; Mishra A; Ashfaque M; Bajpai P
    J Food Biochem; 2022 Oct; 46(10):e14368. PubMed ID: 35945689
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0/A hepatocellular carcinoma: A large-scale multicenter study.
    Feng ZH; Wang MD; Chen Z; Sun LY; Xu X; Kong QY; Chen ZX; Zeng YY; Liang YJ; Chen ZY; Wang H; Zhou YH; Chen TH; Yao LQ; Li C; Pawlik TM; Lau WY; Shen F; Yang T
    Surgery; 2022 Oct; 172(4):1147-1155. PubMed ID: 35868902
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.